Rallybio (NASDAQ:RLYB) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Rallybio (RLYB) operate in?

Rallybio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Rallybio Stock (NASDAQ: RLYB) stock price, news, charts, stock research, profile.

Open	$1.00
Close	-
Volume / Avg.	1.60K / 68.99K
Day Range	$1.00 - $1.00
52 Wk Range	0.95 - 3.46
Market Cap	$40.83M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	1.57%
Days to Cover	4.75

Recent News

Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

Avi Kapoor

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

The weekly Benzinga Stock Whisper Index highlights five stocks that saw increased interest from readers. Here are this week's stocks to watch.

Chris Katje

Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket

Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023 revenues of $37.8 million, up 222% year over year

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.00
Close	-
Volume / Avg.	1.60K / 68.99K
Day Range	$1.00 - $1.00
52 Wk Range	0.95 - 3.46
Market Cap	$40.83M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	1.57%
Days to Cover	4.75

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Rallybio (RLYB) stock?

You can purchase shares of Rallybio (NASDAQ:RLYB) through any online brokerage.

View our list of the best stock brokerages

Who are Rallybio (RLYB) competitors?

Other companies in Rallybio’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), OncoCyte (NASDAQ:OCX) and Gain Therapeutics (NASDAQ:GANX).

What is the forecast, or price target, for Rallybio (RLYB) stock?

Rallybio has a consensus price target of $8.10.

What is the current price for Rallybio (RLYB)?

The stock price for Rallybio (NASDAQ: RLYB) is $1 last updated November 21, 2024 at 9:30 AM EST.

Does Rallybio (RLYB) pay a dividend?

There are no upcoming dividends for Rallybio.

When is Rallybio (NASDAQ:RLYB) reporting earnings?

Rallybio’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is Rallybio (RLYB) going to split?

There is no upcoming split for Rallybio.

What sector and industry does Rallybio (RLYB) operate in?

Rallybio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Rallybio

Rallybio (RLYB) Forecast